The COVID-19 pandemic acted as a catalyst for the widespread adoption of telehealth. Initially driven by necessity, virtual care rapidly became an integral part of healthcare delivery. As we continue to move beyond the acute crisis, telehealth’s role is undergoing transformation, shaping the future of patient-provider interactions. In this article, we explore the nuanced evolution of telehealth, its targeted applications, reimbursement models, and its place in the multichannel healthcare landscape. 

The COVID-19 pandemic acted as a catalyst for the widespread adoption of telehealth. Initially driven by necessity, virtual care rapidly became an integral part of healthcare delivery. As we continue to move beyond the acute crisis, telehealth’s role is undergoing transformation, shaping the future of patient-provider interactions. In this article, we explore the nuanced evolution of telehealth, its targeted applications, reimbursement models, and its place in the multichannel healthcare landscape. 

Fluctuations in Telehealth Use 

The surge in telehealth adoption during the pandemic was unprecedented. Patients, providers, and policymakers embraced virtual visits to maintain continuity of care while adhering to social distancing guidelines. Recent data collected by the American Medical Association (AMA) underscores this transformation. The use of “tele-visits,” including video and phone consultations, surged from 14% in 2016 to 28% in 2019, and remarkably reached 80% in 2022. Telehealth has become an essential tool in healthcare, significantly enhancing accessibility. 

However, as the pandemic gradually waned and in-person care resumed, telehealth usage experienced fluctuations. The initial surge was driven by necessity, but its sustained adoption requires thoughtful integration into the broader healthcare landscape.  

Targeted Use Cases for Telehealth 

Health systems have come to recognize that telehealth is not a one-size-fits-all solution. Instead, it excels in specific contexts, offering tailored benefits. Notably, mental health services have witnessed remarkable growth in telehealth utilization. The transition from traditional in-person therapy to virtual sessions was remarkably seamless, and patients appreciated the convenience and privacy it afforded. As telehealth usage for mental health continues to rise nationally, this trend underscores its effectiveness in addressing critical mental health needs while simultaneously reducing barriers to access. Telehealth mitigates the stigma associated with seeking mental health support. Patients feel more comfortable discussing their emotional well-being in a virtual setting, leading to increased utilization of telehealth services. 

Virtual-First Reimbursement Landscape 

Reimbursement models are evolving to accommodate telehealth’s expanded role. Providers are moving away from a blanket approach and adopting targeted strategies. Rather than replacing all in-person visits, telehealth is now part of a multichannel care delivery system. McKinsey & Company reports “[An] estimate that up to $265 billion worth of care services (representing up to 25 percent of the total cost of care) for Medicare FFS and MA beneficiaries could shift from traditional facilities to the home by 2025 without a reduction in quality or access.” This shift reflects a pragmatic understanding that certain conditions and patient populations can be effectively managed through virtual encounters. 

The Transition Toward Multichannel Strategies   

Gurpreet Singh, health services sector leader at PricewaterhouseCoopers (PwC), describes telehealth as a channel within a broader multichannel strategy. It complements other care options, including in-person visits, urgent care centers, and home health services. Rather than an all-or-nothing replacement, telehealth enhances flexibility and personalization. For routine follow-ups, chronic disease management, and preventive care, patients can choose the most suitable channel based on their preferences and needs. 

Extending beyond patient-provider virtual interactions, biopharmaceutical companies are increasingly building relationships with healthcare providers (HCPs) through digital means. Before the COVID-19 pandemic, a 2018 McKinsey survey revealed that 50% of biopharmaceutical companies preferred face-to-face interactions, with only 10% adopting a virtual format. However, within three years, 90% of these companies were engaging with HCPs digitally. Despite this shift, HCPs feel that the pharmaceutical industry has yet to fully optimize their digital presence, often neglecting the needs of both HCPs and their patients. 

The rise of the multi-platform generation has expanded the channels for healthcare providers (HCPs) and Medical Science Liaisons (MSLs) to access band share bite-sized, easy-to-digest, and trusted information. Shifting from traditional literature reviews to videos, infographics, podcasts, and social media, this approach simplifies information delivery, making it more navigable and interactive. As a result, HCPs and MSLs benefit from more condensed and targeted information and recommendations. 

Moreover, reports indicate that HCPs prefer to spend more time interacting with MSLs than with sales representatives. This industry shift, combined with the rise of virtual interactions, places MSLs in influential positions to effectively "sell science" to HCPs. By adapting to HCPs' preferred methods of receiving information, MSLs are becoming unprecedentedly pivotal in providing essential communication and meaningful digital influence within the healthcare sector. 

The Future of Telehealth 

Looking ahead, telehealth’s trajectory involves strategic integration and targeted applications. Here are some key aspects: 

1. Mental Health Continuum: Telehealth will continue to play a pivotal role in mental health services. The stigma associated with seeking therapy is less pronounced in virtual settings, encouraging more individuals to seek help. Providers can offer counseling, cognitive-behavioral therapy, and crisis intervention via secure video calls. 

1. Chronic Disease Management: Patients with chronic conditions, such as Diabetes, benefit from regular check-ins. Telehealth allows for personalized monitoring, medication adjustments, and lifestyle counseling. By integrating wearable devices and remote monitoring tools, providers can proactively manage chronic diseases. 

1. Preventive Care and Wellness: Telehealth can promote preventive care by facilitating health screenings, vaccinations, and lifestyle counseling. Patients can receive personalized recommendations without leaving their homes, leading to better overall health outcomes. 

1. Rural and Underserved Communities: Telehealth bridges geographical gaps, enabling patients in rural or underserved areas to access specialized care. It reduces travel time, transportation costs, and the burden of seeking care far from home. 

Telehealth’s journey beyond the pandemic involves deliberate adaptation, thoughtful integration, and patient-centered care. As technology advances and policies evolve, telehealth will remain a valuable component of the care continuum. Its impact extends beyond crisis management—it is a transformative force shaping healthcare delivery for years to come. In summary, telehealth is no longer a temporary fix; it is a permanent practice in the healthcare landscape, connecting patients and providers across distances and ensuring equitable access to quality care. 

______

At PFG MedComm, we continuously explore innovative approaches and can help you navigate the complexities of the healthcare payor landscape. Click here to download PFG MedComm’s Ultimate Guide to Market Access.  

Schedule a brief intro to see how we can help!